Declaration of Non Applicability of Annual Secretarial Compliance Report.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Novelix Pharmaceuticals Ltd has declared that the requirement to submit an Annual Secretarial Compliance Report under SEBI Regulation 24A is not applicable to the company. The company cites Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which exempts listed entities with paid-up equity share capital not exceeding Rs 10 crore AND net worth not exceeding Rs 25 crore from secretarial audit compliance. The company confirms it qualifies for this exemption as of March 31, 2025. The filing is signed by Venkateshwarlu, Whole-time Director, and submitted on May 27, 2026.
No immediate shareholder impact — the company is simply asserting a legal exemption from a compliance requirement due to its small size. The stock remains listed and trading on BSE (Code: 516565) with standard obligations otherwise applicable.